Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00398476 · ClinicalTrials.gov registry record · Phase 3
Fluticasone Nasal Spray Patient Preference Study
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 127
- Enrollment target
NCT00398476 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 127 participants.
The verdict
NCT00398476, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 127 participants
- Enrollment target
Study Summary
The objectives of this study are to evaluate and compare patient preference for FF (Fluticasone Furoate) and FP (Fluticasone Propionate Aqueous)nasal sprays in the treatment of allergic rhinitis following single-dose administration.
Interventions
- DRUG fluticasone furoate (FF)
- DRUG fluticasone propionate (FP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2006-12-01 |
| Est. Completion | 2006-12-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00398476
The ClinicalTrials.gov registry entry for NCT00398476 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fluticasone furoate (FF) is the first listed.
NCT00398476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00398476 about?
NCT00398476 is a clinical study titled "Fluticasone Nasal Spray Patient Preference Study". The objectives of this study are to evaluate and compare patient preference for FF (Fluticasone Furoate) and FP (Fluticasone Propionate Aqueous)nasal sprays in the treatment of allergic rhinitis following single-dose administration.
What is the current status of trial NCT00398476?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 127 participants. The study started on 2006-12-01. Estimated completion is 2006-12-04.
What interventions are being tested in trial NCT00398476?
The interventions under investigation include: fluticasone furoate (FF) (DRUG), fluticasone propionate (FP) (DRUG).
Who is sponsoring clinical trial NCT00398476?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.